Image via The Hindu BusinessLine
Last updated
Sun Pharma: Ma Activity
Sun Pharma acquiring Innovcare Lifesciences for ₹271 crore (~$32.5M USD)
Source: The Hindu BusinessLine
The leadership read
Consolidation shifts the leadership question from growth to integration. For Sun Pharma in the sector, the demand moves toward transformation and integration leaders who can merge teams, systems and cultures without losing momentum. Across Asia, watch whether the integration is properly resourced; deals are won or lost the year after they close.
Market context: Backdrop: a 105.8 (Hot) Talent Market Index (down 2.3 on the month) with Asia activity steady (+0.5pts).
Sun Pharma: 1 signal in the last 90 days; 0.1% of MitchelLake's Asia signal flow.
More signals across Asia
Ma Activity · Asia
Capital Group →Capital Group acquired a 1.5% stake in IIFL Finance for ₹374.02 crore at ₹590 per share
“will be instrumental as we continue to expand in the region”
Ma Activity · Asia
Peak XV Partners →Peak XV Partners divested ₹139 Cr (~$16.7M USD) in Go Digit shares via block deal, marking the second major stake reduction in two months (₹100 Cr sold in June). This follows CCI approval of Go Digit Infoworks Services merger with Go Digit General Insurance.
Ma Activity · Asia
WestBridge →WestBridge Capital is considering a sale of its 40% stake in Star Health Insurance, having engaged financial advisers to evaluate the transaction.
Ma Activity · Asia
Veralto →Veralto acquired Alfaa UV, an India-based ultraviolet water treatment systems provider for industrial and commercial applications.
Ma Activity · Asia
KKR →KKR is marketing nine commercial properties across China (Beijing apartments, Shanghai hotel on the Bund) for sale. Expects 50-60% of original purchase prices, indicating major divestment from Chinese real estate.
Ma Activity · Asia
Treasury Wine Estates →Treasury Wine Estates has halted Penfolds Bin 407 orders in China, suggesting potential market contraction or strategic portfolio review
Intelligence powered by Autonodal ↗